Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Presentation TCT 2024

Selution

Presenter: Simon Eccleshall

October 30, 2024

Presentation TCT 2024

Current and Future Clinical Evidence of SELUTION SLR™ DEB

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2024

SELUTION SLR™ DEB Case Example from Europe

Presenter: Luigi Salemme

October 29, 2024

Presentation TCT 2024

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2023

SELUTION DCB

Presenter: Donald Cutlip

October 25, 2023

Presentation TCT 2023

Status Quo on SELUTION4ISR & SELUTION4DeNovo

Presenter: Donald Cutlip

October 24, 2023

Presentation TCT 2023

Sustained Limus Release - The Tale of SELUTION SLR Balloon

Presenter: Alexandre Abizaid

October 24, 2023

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

Presentation TCT 2019

SELUTION SLR: A Sustained Limus Release Drug-Eluting Balloon — First Human Data From a Multicenter Coronary Trial

Presenter: Stephan Windecker

September 27, 2019

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

Advertisement

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

What’s Going to Be Hot at TCT 2025

Selution

Current and Future Clinical Evidence of SELUTION SLR™ DEB

SELUTION SLR™ DEB Case Example from Europe

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

SELUTION DCB

Status Quo on SELUTION4ISR & SELUTION4DeNovo

Sustained Limus Release - The Tale of SELUTION SLR Balloon

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

DCBs in Coronaries? Some Good News, but More Work Needed

SELUTION SLR: A Sustained Limus Release Drug-Eluting Balloon — First Human Data From a Multicenter Coronary Trial

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content